Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy.
暂无分享，去创建一个
T. Choueiri | B. Rini | M. Tan | J. Knox | G. Bjarnason | C. Kollmannsberger | U. Vaishampayan | D. Heng | F. Donskov | L. Wood | S. North | M. Mackenzie | Y. Wang | B. Rini | T. Choueiri